OBJECTIVE: To assess the effects of living in agreement with allergy preventive guidelines on wheezing and asthma at 2 years of age. DESIGN: Prospective birth cohort study (BAMSE). Questionnaires on heredity and environmental factors were answered when the child was 2 months, and detailed questionnaires on symptoms at 1 and 2 years of age. PARTICIPANTS: 4089 children, born during 1994-1996. SETTING: Child Health Centres in central and north-western parts of Stockholm, Sweden. MAIN OUTCOME MEASURES: Wheezing and asthma up to the age of 2. RESULTS: The effects of preventive guidelines regarding breastfeeding, maternal tobacco smoke and home dampness on wheezing and asthma were assessed in multiple logistic regression models. The cumulative incidence of recurrent wheezing at 2 years of age was 12.6% and of asthma 6.8% among those with a lifestyle in agreement with all guidelines and 24.1 and 17.9%, respectively, in families exposed to at least two of the three risk factors. Among children with no heredity, family lifestyle according to the guidelines gave a twofold reduction of asthma (5.3 vs. 10.5%), while the group with heredity had a threefold reduction (9.1 vs. 27.3%). The attributable fraction for asthma associated with the guidelines was 23% in total and 33% among those with heredity. CONCLUSION: In this observational study, family lifestyle according to preventive guidelines is associated with an important reduction of recurrent wheezing and asthma at 2 years of age, especially among children with allergic heredity. A follow-up will determine whether there still a risk reduction of both symptoms and disease.
OBJECTIVE: To assess the effects of living in agreement with allergy preventive guidelines on wheezing and asthma at 2 years of age. DESIGN: Prospective birth cohort study (BAMSE). Questionnaires on heredity and environmental factors were answered when the child was 2 months, and detailed questionnaires on symptoms at 1 and 2 years of age. PARTICIPANTS: 4089 children, born during 1994-1996. SETTING:Child Health Centres in central and north-western parts of Stockholm, Sweden. MAIN OUTCOME MEASURES: Wheezing and asthma up to the age of 2. RESULTS: The effects of preventive guidelines regarding breastfeeding, maternal tobacco smoke and home dampness on wheezing and asthma were assessed in multiple logistic regression models. The cumulative incidence of recurrent wheezing at 2 years of age was 12.6% and of asthma 6.8% among those with a lifestyle in agreement with all guidelines and 24.1 and 17.9%, respectively, in families exposed to at least two of the three risk factors. Among children with no heredity, family lifestyle according to the guidelines gave a twofold reduction of asthma (5.3 vs. 10.5%), while the group with heredity had a threefold reduction (9.1 vs. 27.3%). The attributable fraction for asthma associated with the guidelines was 23% in total and 33% among those with heredity. CONCLUSION: In this observational study, family lifestyle according to preventive guidelines is associated with an important reduction of recurrent wheezing and asthma at 2 years of age, especially among children with allergic heredity. A follow-up will determine whether there still a risk reduction of both symptoms and disease.
Authors: Niloufar Farzan; Susanne J Vijverberg; Anand K Andiappan; Lambang Arianto; Vojko Berce; Natalia Blanca-López; Hans Bisgaard; Klaus Bønnelykke; Esteban G Burchard; Paloma Campo; Glorisa Canino; Bruce Carleton; Juan C Celedón; Fook Tim Chew; Wen Chin Chiang; Michelle M Cloutier; Denis Daley; Herman T Den Dekker; F Nicole Dijk; Liesbeth Duijts; Carlos Flores; Erick Forno; Daniel B Hawcutt; Natalia Hernandez-Pacheco; Johan C de Jongste; Michael Kabesch; Gerard H Koppelman; Vangelis G Manolopoulos; Erik Melén; Somnath Mukhopadhyay; Sara Nilsson; Colin N Palmer; Maria Pino-Yanes; Munir Pirmohamed; Uros Potočnik; Jan A Raaijmakers; Katja Repnik; Maximilian Schieck; Yang Yie Sio; Rosalind L Smyth; Csaba Szalai; Kelan G Tantisira; Steve Turner; Marc P van der Schee; Katia M Verhamme; Anke H Maitland-van der Zee Journal: Pharmacogenomics Date: 2017-06-22 Impact factor: 2.533
Authors: Seung-Hyun Cho; Tiina Reponen; Grace LeMasters; Linda Levin; Jian Huang; Teija Meklin; Patrick Ryan; Manuel Villareal; David Bernstein Journal: Ann Allergy Asthma Immunol Date: 2006-10 Impact factor: 6.347
Authors: Magnus Wickman; Christian Lupinek; Niklas Andersson; Danielle Belgrave; Anna Asarnoj; Marta Benet; Mariona Pinart; Sandra Wieser; Judith Garcia-Aymerich; Alexandra Baar; Göran Pershagen; Angela Simpson; Inger Kull; Anna Bergström; Erik Melén; Carl Hamsten; Josep M Antó; Jean Bousquet; Adnan Custovic; Rudolf Valenta; Marianne van Hage Journal: EBioMedicine Date: 2017-11-14 Impact factor: 8.143
Authors: Kate Marie Lewis; Milagros Ruiz; Peter Goldblatt; Joana Morrison; Daniela Porta; Francesco Forastiere; Daniel Hryhorczuk; Oleksandr Zvinchuk; Marie-Josephe Saurel-Cubizolles; Sandrine Lioret; Isabella Annesi-Maesano; Martine Vrijheid; Maties Torrent; Carmen Iniguez; Isabel Larranaga; Margreet W Harskamp-van Ginkel; Tanja G M Vrijkotte; Jana Klanova; Jan Svancara; Henrique Barross; Sofia Correia; Marjo-Riitta Jarvelin; Anja Taanila; Johnny Ludvigsson; Tomas Faresjo; Michael Marmot; Hynek Pikhart Journal: Eur J Epidemiol Date: 2017-09-19 Impact factor: 8.082
Authors: Leslie Elliott; John Henderson; Kate Northstone; Grace Y Chiu; David Dunson; Stephanie J London Journal: J Allergy Clin Immunol Date: 2008-05-12 Impact factor: 10.793
Authors: B Alm; N Aberg; L Erdes; P Möllborg; R Pettersson; S G Norvenius; E Goksör; G Wennergren Journal: Arch Dis Child Date: 2008-09-25 Impact factor: 3.791